Ekso Bionics Holdings, INC Form 4 insider transactions

Director Mary Ann Cloyd reports acquisition of restricted stock units and disposal of common stock in Ekso Bionics Holdings, Inc.

Director Corinna Lathan reports acquisition of 78,217 restricted stock units in Ekso Bionics Holdings, Inc. following the company's annual meeting.

Director Kecheng Li acquired 78,217 restricted stock units in Ekso Bionics Holdings, Inc., effective June 6, 2024, increasing his total holdings to 224,738 shares.

Director Deborah Lafer Scher reports acquisition of 78,217 restricted stock units (RSUs) in Ekso Bionics Holdings, Inc. following the company's annual meeting.

Jerome Wong, CFO of Ekso Bionics Holdings, Inc., reports acquiring 7,474 shares of common stock through the company's 401(k) contribution matching program on March 22, 2024.

Jason C. Jones, Chief Operating Officer of Ekso Bionics Holdings, Inc., reports acquiring 7,474 shares of common stock through the company's 401(k) contribution matching program.

Jason C. Jones, Chief Operating Officer of Ekso Bionics Holdings, files an amendment to a previous SEC Form 4 to correct the number of shares acquired through the company's 401(k) plan.

Director Corinna Lathan has been actively purchasing Ekso Bionics Holdings, Inc. (EKSO) common stock, increasing her holdings through multiple transactions.